Libra Infusions Limited (DSE:LIBRAINFU)

Market Cap	1.41B -19.8%
Revenue (ttm)	197.03M -19.6%
Net Income	1.58M -68.2%
EPS	0.70 -68.2%
Shares Out	2.25M
PE Ratio	889.40
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,048
Open	626.00
Previous Close	625.90
Day's Range	614.00 - 626.30
52-Week Range	547.10 - 850.00
Beta	-0.35
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Libra Infusions

Libra Infusions Limited manufactures and sells intravenous fluids in Bangladesh. Its products are used in medical situations, including diarrhoeal disease, surgical operation, loss of blood, weakness, and hospitalization. The company offers LIBOTT, LIBOTT-10, LIBOTT-25, LIBOTT-S, LIBOTT-S JR, NORMASOL, BABY SALINE, DIASOL, HARTSOL, LIBRAZOL, LIBRACIN, LIBOTT-M, LIBRACIN-400, and LIBRET products. The company was formerly known as Libra Pharmaceutical Limited and changed its name to Libra Infusions Limited in 1999. Libra Infusions Limited was inc...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 699
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: LIBRAINFU